Angiogenic activity of fibrin degradation products is located in fibrin fragment E
The DOI matches its Crossref record.
Abstract
The source of angiogenic activity of fibrin degradation products has been sought in a series of experiments, applying degradation products from different types of fibrin and fibrinogen to the chick chorioallantoic membrane. The presence of platelets or fibronectin during clotting was not essential for activity, and neither was crosslinking. Fibrinogen degradation products were non‐stimulatory, as was serum. Molecular sieve column chromatography indicated a range of active fragments. Admixture of active fibrin degradation products with antifibrin fragment E, but not D, antiserum neutralized activity. Preparations containing only fibrin fragment E retained activity. A commercial preparation of fibrinogen fragment E was inactive until treated with thrombin. These experiments point to fibrin fragment E being the source of angiogenic activity, with thrombin cleavage being the essential step in generating activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells
Palumbo, J. S., Kombrinck, K. W., Drew, A. F., Grimes, T. S., Kiser, J. H., Degen, J. L., & Bugge, T. H. (2000) · Blood · doi:10.1182/blood.v96.10.3302 · Cited by 605
Christman, K. L., Vardanian, A. J., Fang, Q., Sievers, R. E., Fok, H. H., & Lee, R. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.04.040 · Cited by 545
The post-PE syndrome: a new concept for chronic complications of pulmonary embolism
Klok, F. A., van der Hulle, T., den Exter, P. L., Lankeit, M., Huisman, M. V., & Konstantinides, S. (2014) · Blood Reviews · doi:10.1016/j.blre.2014.07.003 · Cited by 441
Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors
Crowther, M., Brown, N. J., Bishop, E. T., & Lewis, C. E. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.4.478 · Cited by 415
Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo
Ling, Q., Jacovina, A. T., Deora, A., Febbraio, M., Simantov, R., Silverstein, R. L., Hempstead, B., Mark, W. H., & Hajjar, K. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19684 · Cited by 381
Tissue Factor, Thrombin, and Cancer
Rickles, F. R., Patierno, S., & Fernandez, P. M. (2003) · Chest · doi:10.1378/chest.124.3_suppl.58s · Cited by 378
Role of macrophages in tumour progression
Siveen, K. S., & Kuttan, G. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.02.011 · Cited by 353
High D-dimer levels are associated with poor prognosis in cancer patients
Ay, C., Dunkler, D., Pirker, R., Thaler, J., Quehenberger, P., Wagner, O., Zielinski, C., & Pabinger, I. (2012) · Haematologica · doi:10.3324/haematol.2011.054718 · Cited by 340
Brown, A. C., & Barker, T. H. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.09.008 · Cited by 284
Myocardial tissue engineering: a review
Jawad, H., Ali, N. N., Lyon, A. R., Chen, Q. Z., Harding, S. E., & Boccaccini, A. R. (2007) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.46 · Cited by 264
Platelets: Linking Hemostasis and Cancer
Jain, S., Harris, J., & Ware, J. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207514 · Cited by 232
Morris, T. A., Marsh, J. J., Chiles, P. G., Auger, W. R., Fedullo, P. F., & Woods, V. L. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200506-916oc · Cited by 160
“Fibrinolytic resistance that causes persistence of the N-terminus of the -chain of fibrin, as we observed in patients with CTEPH, is particularly interesting to us because this segment has been implicated in a variety of physiologic events, including cell signaling (16) and angiogenesis (17).”
BackgroundExtracellular matrix-inspired biomaterials for wound healing
Hosty, L., Heatherington, T., Quondamatteo, F., & Browne, S. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09750-9 · Cited by 63
“Similarly, in fibrin-based biomaterials, plasmin-mediated fibrinolysis and the breakdown of the fibrin complex forms multiple fragments, with fragment E playing a pro-angiogenic role in wound healing [162 ].”
BackgroundPereira, R. V. S., EzEldeen, M., Ugarte-Berzal, E., Martens, E., Malengier-Devlies, B., Vandooren, J., Vranckx, J. J., Matthys, P., & Opdenakker, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1170153 · Cited by 48
Silk fibroin as adjuvant in the fabrication of mechanically stable fibrin biocomposites
El Maachi, I., Kyriakou, S., Rütten, S., Kopp, A., Köpf, M., Jockenhoevel, S., & Fernández-Colino, A. (2022) · Polymers · doi:10.3390/polym14112251 · Cited by 7
“Additionally, fibrin degradation products are also acknowledged as important modulators of wound healing [24,25].”
Background
Metadata
- Authors
- Thompson, W. D., Smith, E. B., Stirk, C. M., Marshall, F. I., Stout, A. J., & Kocchar, A.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 1992-09
- Volume
- 168
- Issue
- 1
- Pages
- 47-53
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W2001147993
- Cited by
- 110
- References
- 0
- FWCI
- 2.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.